The European Union Drugs Agency (EUDA) is the leading authority on illicit drugs in Europe. Based in Lisbon, Portugal, the EUDA provides independent scientific evidence and analysis on all aspects of this constantly changing threat to individual lives and wider society. The EUDA contributes to EU and national policies to protect Europe's citizens from drug-related harms. It is an agency of the European Union.
Our new mission focuses on contributing to European Union (EU) preparedness on drugs through four main actions: anticipate, alert, respond, and learn.
Date: 15 December 2026, 12:00–13:30 Lisbon time (WET) — 13:00–14:30 (CET).
This webinar will focus on the co-occurrence of mental health and substance use disorders among people in prison. It will also cover the broader mental health and well-being needs of people in prison, including those that may not be captured by a formal diagnosis.
Date: 04 November 2026, 12:00–13:30 Lisbon time (WET) — 13:00–14:30 (CET).
Objectives
The webinar aims to:
Objective: This webinar will provide an overview of mental health risks associated with cannabis use. Participants will hear about the findings on how cannabis use is linked to anxiety, depression, psychotic symptoms and cannabis use disorder, and how cannabis type, potency, and use patterns might increase the risks.
Objective: To create an opportunity for civil society organisations (CSOs) and EUDA to exchange views on the current European drug situation and reflect on its implications from institutional, community and civil society perspectives.
Objective: To mark International Overdose Awareness Day on 31 August, this webinar convenes policy, practice, research and community voices to discuss compassionate, evidence-informed and practical actions that can prevent opioid-related deaths across Europe.
Objective: This webinar will provide an overview of dual disorders (DD), introduce the recently launched EUDA health and social responses miniguide, and offer practical insights from EU-based initiatives. Participants will gain a clearer understanding of the challenges associated with co-occurring mental health and substance use disorders, as well as examples of how these are being addressed in different contexts.
